Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.52 |
| ▸ | LPL | P06858 | 8/20 | 0.52 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14506121 | 0.90 | LIPG (0.60) | LIPGLPLPDK2DGAT1IRAK4 | |
| SCHEMBL17141998 | 0.89 | LIPG (0.54) | LIPGLPLPDK2ESR1ESR2 | |
| SCHEMBL428648 | 0.89 | LPL (0.41) | LIPGLPLPDK2ESR1ESR2 | |
| SCHEMBL14506122 | 0.86 | LIPG (0.64) | LIPGLPLDGAT1IRAK4SNCA | |
| SCHEMBL16577936 | 0.86 | LIPG (0.42) | LIPGLPLPDK2ESR1ESR2 | |
| SCHEMBL12781953 | 0.85 | LIPG (0.52) | LIPGLPLPDK2DGAT1HIF1A | |
| SCHEMBL12781966 | 0.85 | LIPG (0.55) | LIPGLPLPDK2DGAT1HIF1A | |
| SCHEMBL13414970 | 0.84 | LIPG (0.67) | LIPGLPLDGAT1SNCA | |
| SCHEMBL426662 | 0.84 | LPL (0.44) | LIPGLPLPDK2ESR1ESR2 | |
| SCHEMBL13040457 | 0.84 | LPL (0.44) | LIPGLPLPDK2ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9876174-B2 | Electronic device including a fluoranthene derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-01-23 | — | — | US | disclosed |
| US-9876174-B2 | Electronic device including a fluoranthene derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-01-23 | — | — | US | disclosed |
| US-9876174-B2 | Electronic device including a fluoranthene derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-01-23 | — | — | US | disclosed |
| US-9716233-B2 | Electronic device including a fluoranthene derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-07-25 | — | — | US | disclosed |
| US-9716233-B2 | Electronic device including a fluoranthene derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-07-25 | — | — | US | disclosed |
| US-9716233-B2 | Electronic device including a fluoranthene derivative | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-07-25 | — | — | US | disclosed |
| US-20170200900-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200900-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200900-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20160268514-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-09-15 | — | — | US | disclosed |
| US-20160268514-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-09-15 | — | — | US | disclosed |
| US-20160268514-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2016-09-15 | — | — | US | disclosed |
| WO-2015061074-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015061074-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160268514-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | NR0B1, AR, NR0B2 | LIPG 4619/4885LPL 3105/4885PDK2 3733/4885 |
| US-20170200900-A1 | ELECTRONIC DEVICE INCLUDING A FLUORANTHENE DERIVATIVE | AR, CCND3, ESRRA | LIPG 4768/4885LPL 4074/4885PDK2 3652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.